Wang Y - Search Results

1

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation.

Shen MZ, Liu XX, Qiu ZY, Xu LP, Zhang XH, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu SN, Liu KY, Huang XJ, Mo XD. Shen MZ, et al. Among authors: wang fr, wang jz, wang y. Ther Adv Hematol. 2022 Jan 20;13:20406207211072838. doi: 10.1177/20406207211072838. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35096361 Free PMC article.

2

Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia.

Huang XJ, Liu DH, Liu KY, Xu LP, Chen YH, Wang Y, Han W, Chen H. Huang XJ, et al. Among authors: wang y. J Clin Immunol. 2008 May;28(3):276-83. doi: 10.1007/s10875-007-9166-z. J Clin Immunol. 2008. PMID: 18204965

3

Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study.

Liu K, Chen Y, Zeng Y, Xu L, Liu D, Chen H, Zhang X, Han W, Wang Y, Zhao T, Wang J, Wang J, Han Q, Zhao C, Huang X. Liu K, et al. Among authors: wang j, wang y. Stem Cells Dev. 2011 Oct;20(10):1679-85. doi: 10.1089/scd.2010.0447. Epub 2011 Feb 5. Stem Cells Dev. 2011. PMID: 21142788 Clinical Trial.

4

[The efficacy and safety of donor lymphocyte infusion to treat Epstein-Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation].

Xu LP, Liu DH, Liu KY, Chen H, Han W, Wang Y, Wang J, Shi HX, Huang XJ. Xu LP, et al. Among authors: wang j, wang y. Zhonghua Nei Ke Za Zhi. 2010 Nov;49(11):955-8. Zhonghua Nei Ke Za Zhi. 2010. PMID: 21211211 Chinese.

5

[A comparative study of different intervention regimens for chronic myelogenous leukemia post allogeneic hematopoietic stem cell transplantation].

Xu LP, Liu DH, Liu KY, Chen H, Han W, Zhang XH, Chen YH, Wang Y, Qin YZ, Huang XJ. Xu LP, et al. Among authors: wang y. Zhonghua Xue Ye Xue Za Zhi. 2010 Nov;31(11):758-62. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 21223731 Chinese.

6

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.

Jiang Q, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B, Jiang H, Chen H, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Lai YY, Huang XJ. Jiang Q, et al. Among authors: wang y. Blood. 2011 Mar 17;117(11):3032-40. doi: 10.1182/blood-2010-09-308510. Epub 2011 Jan 20. Blood. 2011. PMID: 21252092 Free article. Clinical Trial.

7

Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Chen H, Liu KY, Xu LP, Liu DH, Chen YH, Shi HX, Han W, Zhan XH, Wang Y, Zhao T, Huang XJ. Chen H, et al. Among authors: wang y. Chin Med J (Engl). 2011 Jan;124(2):246-52. Chin Med J (Engl). 2011. PMID: 21362375 Clinical Trial.

8

The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation.

Liu DH, Zhao XS, Chang YJ, Liu YK, Xu LP, Chen H, Han W, Chen YH, Wang Y, Huang XJ. Liu DH, et al. Among authors: wang y. Pediatr Blood Cancer. 2011 Jul 15;57(1):135-41. doi: 10.1002/pbc.23107. Epub 2011 Mar 17. Pediatr Blood Cancer. 2011. PMID: 21416583

9

[The efficacy and safety of mismatched hematopoietic stem cell transplantation for treatment of severe aplastic anemia].

Han W, Huang XJ, Liu KY, Xu LP, Liu DH, Chen H, Zhang XH, Chen YH, Wang FR, Wang Y. Han W, et al. Among authors: wang fr, wang y. Zhonghua Nei Ke Za Zhi. 2011 Apr;50(4):287-90. Zhonghua Nei Ke Za Zhi. 2011. PMID: 21600145 Chinese.

10

Higher proportions of peripheral CD19+CD5+ B cells predict the effect of corticosteroid in patients with late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Fu HX, Xu LP, Liu DH, Liu KY, Chen H, Han W, Zhang XH, Wang Y, Wang FR, Wang JZ, Zhao T, Zhang YY, Chen Y, Huang XJ. Fu HX, et al. Among authors: wang fr, wang jz, wang y. Chin Med J (Engl). 2011 May;124(10):1517-23. Chin Med J (Engl). 2011. PMID: 21740809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272,107 results

Search Page